Psychiatry & Neurology Doctors in Madison Heights, MI Accepting Medicare

4 Psychiatry & Neurology doctors found. Showing 1 - 4

Santosh K Rastogi, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7480

Philip Ross, D.O. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7795    Fax: 248-967-7794

Mary Mossad Megally, D.O. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 27301 Dequindre Rd, Suite 103, Madison Heights, MI 48071 Phone: 248-541-2551    Fax: 248-541-1405

Adam Howard Kuhlman, D.O. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 27351 Dequindre Rd, Madison Heights, MI 48071 Phone: 248-967-7795    Fax: 248-967-7794

News Archive

MD Anderson-led study explores role of HIF-1 in triple-negative breast cancer

A multi-institutional international study led by scientists at The University of Texas MD Anderson Cancer Center has revealed new information about how molecules called long non-coding RNAs (lncRNA) interact with HIF-1, a signaling pathway that is overexpressed in many cancers. HIF-1 has been shown to regulate breast cancer progression.

New method for detecting premature birth

Researchers at Oregon Health & Science University have discovered a method for detecting intra-amniotic infections in pregnant women using state-of-the-art methods.

Report: Improper prescription drug use drives up cost of care

Doctors and hospitals could save the U.S. $213 billion annually if they used prescription drugs more wisely, according to IMS health.

Electrode placement affects subthalamic nucleus stimulation outcomes

Researchers have identified factors associated with motor, cognitive and mood outcomes after deep-brain stimulation (DBS) of the subthalamic nucleus in a large cohort of patients with Parkinson's disease.

FDA approves scan to detect Alzheimer's disease early

The test uses a chemical called florbetapir, known by the brand name Amyvid, which is a radioactive agent that tags clumps of a sticky substance called an amyloid. Amyloid proteins are hallmarks of Alzheimer's disease. The chemical, which costs $1,600 per dose, then is detected using a brain imaging technique called positron emission tomography, known as PET scans. For patients who already have some symptoms of cognitive decline, a positive scan suggests that moderate to frequent amyloid plaques are present in the brain, which is consistent with Alzheimer's disease.

Read more Medical News

› Verified 2 days ago